|
Bioss
rabbit anti spag6 antibody ![]() Rabbit Anti Spag6 Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spag6/SPAG6+Polyclonal+Antibody/pmc08607346-76-9-17 Average 94 stars, based on 1 article reviews
rabbit anti spag6 antibody - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Proteintech
spag6 ![]() Spag6, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spag6/SPAG6+Antibody/pm37001189-63-4-11 Average 93 stars, based on 1 article reviews
spag6 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Novus Biologicals
primary antibodies ![]() Primary Antibodies, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spag6/SPAG6+Antibody+(2F3)/pmc04714969-244-0-6 Average 90 stars, based on 1 article reviews
primary antibodies - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
anti spag6 ![]() Anti Spag6, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spag6/SPAG6+Antibody/pm34663514-52-27-30 Average 90 stars, based on 1 article reviews
anti spag6 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Atlas Antibodies
spag6 ![]() Spag6, supplied by Atlas Antibodies, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spag6/Anti-SPAG6/pmc05033889-458-43-51 Average 85 stars, based on 1 article reviews
spag6 - by Bioz Stars,
2026-11
85/100 stars
|
Buy from Supplier |
|
Thermo Fisher
gene exp spag6 hs00542625 m1 ![]() Gene Exp Spag6 Hs00542625 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spag6/Gene+Exp%2E+SPAG6%2C+Hs00542625_m1/pmc05240214-68-10-23 Average 88 stars, based on 1 article reviews
gene exp spag6 hs00542625 m1 - by Bioz Stars,
2026-11
88/100 stars
|
Buy from Supplier |
|
Bioss
cy3 conjugated goat anti rabbit igg ![]() Cy3 Conjugated Goat Anti Rabbit Igg, supplied by Bioss, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spag6/SPAG6+Polyclonal+Antibody%2C+Cy3+Conjugated/pm35705143-62-18-27 Average 91 stars, based on 1 article reviews
cy3 conjugated goat anti rabbit igg - by Bioz Stars,
2026-11
91/100 stars
|
Buy from Supplier |
|
Jackson Laboratory
homozygous spag6 global knockout mice ![]() Homozygous Spag6 Global Knockout Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spag6/homozygous+spag6+global+knockout+mice/pm35159146-68-3-11 Average 90 stars, based on 1 article reviews
homozygous spag6 global knockout mice - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Abnova
mouse anti-spag6 antibody ![]() Mouse Anti Spag6 Antibody, supplied by Abnova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spag6/mouse+anti+spag6+antibody/pmc11072088-559-134-138 Average 90 stars, based on 1 article reviews
mouse anti-spag6 antibody - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Bioscientifica Ltd
spag6 protein ![]() Spag6 Protein, supplied by Bioscientifica Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spag6/spag6+antibody/10__1530_slash_rep___18___0522-315-14-31 Average 90 stars, based on 1 article reviews
spag6 protein - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
CH Instruments
spag6 biomarker ![]() Spag6 Biomarker, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spag6/spag6+biomarker/10__1016_slash_j__aoas__2023__05__001-213-10-20 Average 90 stars, based on 1 article reviews
spag6 biomarker - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
VectorBuilder GmbH
overexpressed dna plasmid of spag6 ![]() Overexpressed Dna Plasmid Of Spag6, supplied by VectorBuilder GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spag6/overexpressed+dna+plasmid+of+spag6/pmc09641444-95-10-0 Average 90 stars, based on 1 article reviews
overexpressed dna plasmid of spag6 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Oncology Letters
Article Title: Aberrant expression of SPAG6 may affect the disease phenotype and serve as a tumor biomarker in BCR/ABL1-negative myeloproliferative neoplasms
doi: 10.3892/ol.2021.13128
Figure Lengend Snippet: Study design. AML, acute myeloid leukemia; ET, essential thrombocythemia; MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasm; PMF, primary myelofibrosis; PV, polycythemia vera; RT-qPCR, reverse transcription-quantitative PCR; SPAG6, sperm-associated antigen 6; WB, western blotting.
Article Snippet: Following these incubations, the slides were incubated with a
Techniques: Quantitative RT-PCR, Real-time Polymerase Chain Reaction, Western Blot
Journal: Oncology Letters
Article Title: Aberrant expression of SPAG6 may affect the disease phenotype and serve as a tumor biomarker in BCR/ABL1-negative myeloproliferative neoplasms
doi: 10.3892/ol.2021.13128
Figure Lengend Snippet: Relative expression levels and immunoreactivity H-score of SPAG6. (A) SPAG6 mRNA expression in (a) PV, ET, PMF and healthy control groups, and (b) MPN, MDS, AML and healthy control groups. (B) H-score of SPAG6 immunoreactivity in PV, ET, PMF and healthy control groups. ***P<0.01. AML, acute myeloid leukemia; ET, essential thrombocythemia; MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasm; PMF, primary myelofibrosis; PV, polycythemia vera; SPAG6, sperm-associated antigen 6.
Article Snippet: Following these incubations, the slides were incubated with a
Techniques: Expressing
Journal: Oncology Letters
Article Title: Aberrant expression of SPAG6 may affect the disease phenotype and serve as a tumor biomarker in BCR/ABL1-negative myeloproliferative neoplasms
doi: 10.3892/ol.2021.13128
Figure Lengend Snippet: Representative immunohistochemical findings in all myeloproliferative neoplasm groups. Immunohistochemical analysis of sperm-associated antigen 6 expression was performed using paraffin-embedded bone marrow biopsy specimens. ET (upper panels), PV (middle panels) and PMF (lower panels). Negative control (left panels), low expression (center panels) and high expression (right panels). Magnification, ×400. ET, essential thrombocythemia; PMF, primary myelofibrosis; PV, polycythemia vera.
Article Snippet: Following these incubations, the slides were incubated with a
Techniques: Immunohistochemical staining, Expressing, Negative Control
Journal: Oncology Letters
Article Title: Aberrant expression of SPAG6 may affect the disease phenotype and serve as a tumor biomarker in BCR/ABL1-negative myeloproliferative neoplasms
doi: 10.3892/ol.2021.13128
Figure Lengend Snippet: Cell populations expressing SPAG6 in patients with myeloproliferative neoplasms. Sections were stained using H&E staining (left panels) and SPAG6 IHC staining (right panels). Original magnification, ×1,000. The arrows point to the cell types indicated on the left. @, osteocyte; #, osteoblast; and &, osteogenic. IHC, immunohistochemistry; SPAG6, sperm-associated antigen 6.
Article Snippet: Following these incubations, the slides were incubated with a
Techniques: Expressing, Staining, Immunohistochemistry
Journal: Oncology Letters
Article Title: Aberrant expression of SPAG6 may affect the disease phenotype and serve as a tumor biomarker in BCR/ABL1-negative myeloproliferative neoplasms
doi: 10.3892/ol.2021.13128
Figure Lengend Snippet: Subcellular localization patterns of SPAG6 protein in patients with myeloproliferative neoplasms. (A) Subcellular localization pattern of SPAG6 protein in the same patient. Immunohistochemical staining (upper panel) and immunofluorescence staining (lower panel) of SPAG6. (B) Subcellular localization pattern of SPAG6 protein in the same cell type. Nucleated erythroid precursors (upper two rows of panels; inside the red circles) and megakaryocytes (lower two rows of panels). Magnification, ×1,000. @, nucleic localization; *, cytoplasmic localization; #, nucleic and cytoplasmic localization; and &, megakaryocyte. SPAG6, sperm-associated antigen 6.
Article Snippet: Following these incubations, the slides were incubated with a
Techniques: Immunohistochemical staining, Staining, Immunofluorescence
Journal: Oncology Letters
Article Title: Aberrant expression of SPAG6 may affect the disease phenotype and serve as a tumor biomarker in BCR/ABL1-negative myeloproliferative neoplasms
doi: 10.3892/ol.2021.13128
Figure Lengend Snippet: Double immunofluorescence staining of SPAG6 and β-tubulin expression in bone marrow biopsy specimens from patients with myeloproliferative neoplasms. ET (upper panels), PV (middle panels) and PMF (lower panels). Green fluorescence represents SPAG6 staining and red fluorescence represents β-tubulin staining. Blue staining is DAPI nuclear stain. Merged images (right panels; DAPI + SPAG6 + β-tubulin). Original magnification, ×1,000. ET, essential thrombocythemia; PMF, primary myelofibrosis; PV, polycythemia vera; SPAG6, sperm-associated antigen 6.
Article Snippet: Following these incubations, the slides were incubated with a
Techniques: Double Immunofluorescence Staining, Expressing, Fluorescence, Staining
Journal: Oncology Letters
Article Title: Aberrant expression of SPAG6 may affect the disease phenotype and serve as a tumor biomarker in BCR/ABL1-negative myeloproliferative neoplasms
doi: 10.3892/ol.2021.13128
Figure Lengend Snippet: Association between SPAG6 expression and clinical characteristics of patients with myeloproliferative neoplasms.
Article Snippet: Following these incubations, the slides were incubated with a
Techniques: Expressing, Mutagenesis
Journal: Oncology Letters
Article Title: Aberrant expression of SPAG6 may affect the disease phenotype and serve as a tumor biomarker in BCR/ABL1-negative myeloproliferative neoplasms
doi: 10.3892/ol.2021.13128
Figure Lengend Snippet: Receiver operating characteristic curve analysis of SPAG6 expression for distinguishing patients with MPNs from healthy controls, based on the H-score of SPAG6 immunoreactivity. (A) All patients with MPNs (95% CI, 0.8710-0.9556; sensitivity, 81.98%; specificity, 95.65%). Patients with (B) PV (95% CI, 0.8618-0.9815; sensitivity, 83.33%; specificity, 95.65%), (C) ET (95% CI, 0.8827-0.9729; sensitivity, 82.80%; specificity, 100.00%) and (D) PMF (95% CI, 0.7605-0.9533; sensitivity, 67.74%; specificity, 81.43%). AUC, area under the curve; ET, essential thrombocythemia; MPN, myeloproliferative neoplasm; PMF, primary myelofibrosis; PV, polycythemia vera; SPAG6, sperm-associated antigen 6.
Article Snippet: Following these incubations, the slides were incubated with a
Techniques: Expressing
Journal: Ecotoxicology and environmental safety
Article Title: Microcystin leucine arginine induces human sperm damage: Involvement of the Ca 2+ /CaMKKβ/AMPK pathway.
doi: 10.1016/j.ecoenv.2023.114845
Figure Lengend Snippet: Fig. 5. Effect of MC-LR exposure on human sperm flagellum A. The “9 + 2′′ structure of the sperm flagellum was observed using transmission electron microscopy. Red arrows: the CMs was asymmetrically distributed. Green arrows: the MDs were off to one side. Yellow arrows: the MDs were absent. B. The mRNA levels of SPAG16, SPAG6, CFAP44, DNAH17, and SPEF2 were measured by RT-qPCR. C and D. The location of DNAH17 and SPEF2 proteins in sperm were assessed using Immunofluorescence. E and F: The expression levels of sperm flagellum-associated proteins SPAG16, SPAG6, and CFAP44 were detected using Western blotting. The internal reference protein is GAPDH. All exposure times were chosen to be 6 h. * represented statistically significant differences (p < 0.05) compared to the control group in the same period.
Article Snippet: The antibodies of SPAG16,
Techniques: Transmission Assay, Electron Microscopy, Quantitative RT-PCR, Immunofluorescence, Expressing, Western Blot, Control
Journal: Ecotoxicology and environmental safety
Article Title: Microcystin leucine arginine induces human sperm damage: Involvement of the Ca 2+ /CaMKKβ/AMPK pathway.
doi: 10.1016/j.ecoenv.2023.114845
Figure Lengend Snippet: Fig. 7. Possible mechanism of MC-LR-caused sperm dysfunction and flagellar structural damage through the Ca2þ/CaMKKβ/AMPK pathway. After entering human sperm, MC-LR inhibits the phosphorylation of CaMKK by reducing the concentration of calcium ions in the sperm, further resulting in a decrease in the phosphorylation of AMPK. The inhibition of the Ca2+/CaMKKβ/ AMPK pathway reduces flagellar structural proteins (CFAP44, DNAH17, SPEG2 and SPAG6/16) and decreases viability, motility and capacitation of human sperm.
Article Snippet: The antibodies of SPAG16,
Techniques: Phospho-proteomics, Concentration Assay, Inhibition
Journal: Molecular Cancer
Article Title: SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers
doi: 10.1186/s12943-016-0568-5
Figure Lengend Snippet: SPAG6 and L1TD1 mRNA expression in TU and corresponding NL samples of NSCLC patients in TCGA datasets. Comparison of SPAG6 a and L1TD1 b mRNA expression in TU and NL samples of 57 adenocarcinoma (LUAD dataset) and 51 squamous cell carcinoma patients (LUSC dataset), respectively. Normalized log2 expression values are shown, **** p < 0.0001. Only patients with matched TU and NL samples were used for this analysis. TU, primary tumor sample; NL, normal lung tissue sample
Article Snippet: Expression of SPAG6 was determined using Taqman Gene Expression Assays
Techniques: Expressing, Comparison
Journal: Molecular Cancer
Article Title: SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers
doi: 10.1186/s12943-016-0568-5
Figure Lengend Snippet: Expression and methylation analyses of SPAG6 and L1TD1 in NHBECS and in NSCLC cell lines. a By RT-PCR SPAG6 mRNA was found to be downregulated in NSCLC cell lines but not in NHBECs. In contrast, SPAG6 methylation was observed in all NSCLC cell lines with downregulated mRNA expression but not in NHBECs by MS-HRM analysis. b SPAG6 methylated cells were treated with 5-AzadC alone or with a combination of 5-AzadC and TSA. RT-PCR analyses revealed upregulation of SPAG6 expression after drug treatment. Fold changes of gene expression in treated cells compared to untreated cells are shown. c Results from BGS of a part of the SPAG6 5′ region in NHBECs, A549 and NCI-H1975 cells are shown. 56 CpG sites (indicated as pink bars) were analysed for SPAG6 methylation. TSS, transcription start site, black squares indicate methylated CpG sites, white squares unmethylated CpG sites. Analyses of BGS results of the SPAG6 5′ region showed statistically significant differences of methylated CpG sites between NHBCEs and NSCLC cells (**** p < 0.0001). d L1TD1 mRNA was found to be downregulated in NSCLC cell lines but not in NHBECs by RT-PCR. By MS-HRM analysis L1TD1 methylation was detected in all NSCLC cell lines with downregulated mRNA expression but not in NHBECs. e L1TD1 methylated cells were treated with epigenetically active drugs. RT-PCR analyses revealed upregulation of L1TD1 expression after drug treatment. Fold changes of gene expression in treated cells compared to untreated cells are shown. f Results from BGS of a part of the L1TD1 5′ region in NHBECs, A549 and NCI-H1650 cells are shown. Twenty-four CpG sites were analysed for L1TD1 methylation. TSS, transcription start site, black squares indicate methylated CpG sites, white squares unmethylated CpG sites and grey squares intermediate methylation. Analysis of BGS results of the L1TD1 5′ region showed statistically significant differences of methylated CpG sites between NHBCEs and NSCLC cells (**** p < 0.0001)
Article Snippet: Expression of SPAG6 was determined using Taqman Gene Expression Assays
Techniques: Expressing, Methylation, Reverse Transcription Polymerase Chain Reaction, Gene Expression, BGS-A
Journal: Molecular Cancer
Article Title: SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers
doi: 10.1186/s12943-016-0568-5
Figure Lengend Snippet: SPAG6 and L1TD1 methylation in NSCLC patients. Comparison of SPAG6 a and L1TD1 b methylation percentages in TU and NL samples of 146 NSCLC patients with each dot representing methylation percentages in an individual sample revealed statistically significant differences (**** p < 0.0001). ROC curve analyses demonstrated that the extent of SPAG6 a and L1TD1 b methylation is able to distinguish between TU and NL samples. Blue line, reference line; red line, methylation of SPAG6 ; AUC, area under the curve; CI, confidence interval; TU, primary tumor sample; NL, normal lung tissue sample
Article Snippet: Expression of SPAG6 was determined using Taqman Gene Expression Assays
Techniques: Methylation, Comparison
Journal: Molecular Cancer
Article Title: SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers
doi: 10.1186/s12943-016-0568-5
Figure Lengend Snippet: Protein expression of SPAG6 and L1TD1 in NSCLC patients. Representative IHC stainings of NL and TU samples are shown. In unmethylated NL samples cytoplasmic expression of SPAG6 a and L1TD1 b was observed in bronchial and bronchiolar epithelial cells. In SPAG6 a , respectively, L1TD 1 b methylated TU samples neither SPAG6 nor L1TD1 expression was observed in tumor cells. c The comparison between SPAG6 and L1TD1 protein expression and SPAG6 or L1TD1 methylation by T/N methylation ratios and IHC groupings of 35 TU samples is shown
Article Snippet: Expression of SPAG6 was determined using Taqman Gene Expression Assays
Techniques: Expressing, Methylation, Comparison
Journal: Cellular and Molecular Life Sciences: CMLS
Article Title: CCDC146 is required for sperm flagellum biogenesis and male fertility in mice
doi: 10.1007/s00018-023-05025-x
Figure Lengend Snippet: CCDC146 may facilitate ODF2 transportation by interacting with CCDC42 and CCDC38. A-C CCDC146 co-localized with γ-TUBULIN, CCDC38, and CCDC42 in NIH3T3 cells before serum starvation. pCSII-MYC-Ccdc146 and pEGFP-C1-Ccdc38 or pEGFP-C1-Ccdc42 were co-transfected into NIH3T3 cells. 24 h after transfection, cells were fixed and stained with anti-MYC and anti-GFP antibodies, and the nucleus was stained with DAPI. D CCDC42 cannot co-localize with Ac-TUBULIN in NIH3T3 cells during ciliogenesis. pEGFP-C1-Ccdc42 were transfected into NIH3T3 cells. After serum starvation, cells were fixed and stained with anti-GFP and anti-Ac-TUBULIN antibodies, and the nucleus was stained with DAPI. E CCDC38 co-localized with Ac-TUBULIN in NIH3T3 cells during ciliogenesis. pEGFP-C1-Ccdc38 were transfected into NIH3T3 cells. After serum starvation, cells were fixed and stained with anti-GFP and anti-Ac-TUBULIN antibodies, and the nucleus was stained with DAPI. F CCDC146 cannot co-localize with Ac-TUBULIN in NIH3T3 cells during ciliogenesis. pCSII-MYC-Ccdc146 were transfected into NIH3T3 cells. After serum starvation, cells were fixed and stained with anti-MYC and anti-Ac-TUBULIN antibodies, and the nucleus was stained with DAPI. G The immunofluorescence of CCDC146 in Ccdc146+/+ and Ccdc146−/− mice. Testis germ cells were stained with anti-CCDC146 antibody, and the nucleus was stained with DAPI. H The immunofluorescence of CCDC146 in Ccdc146+/+ and Ccdc146−/− mice. Spermatozoa from cauda of the epididymis were stained with anti-CCDC146 antibody, and the nucleus was stained with DAPI. Scale bars: 2·5 μm (A-F); 5 μm (G); 10 μm (A-F, H). I CCDC146 may interact with microtubule proteins and microtubule inner proteins. Co-IP of sperm flagellum proteins with FLAG-CCDC146 from testis lysate using anti-FLAG magnetic beads, followed by western blotting with anti-α-TUBULIN, anti-β-TUBULIN, anti-TEKT2, anti-SPACA9, anti-DYNLL2, anti-PPIL6, anti-NME5, anti-SPAG6, anti-SPAG16, and anti-FLAG (CCDC146) antibodies. MT microtubule; MIP microtubule inner protein; RS radial spoke; CPA central-pair apparatus
Article Snippet: Antibodies The following primary antibodies were used for immunofluorescence (IF) and western blotting (WB): mouse anti-GFP (M20004, Abmart; 1:1000 for WB), rabbit anti-MYC (BE2011, EASYBIO; 1:1000 for WB), anti-ODF2 (12058-1-AP, Proteintech; 1:500 for WB, 1:200 for IF), anti-ODF1 (24736-1-AP, Proteintech; 1:1000 for WB), mouse anti-α-Tubulin antibody (AC012, ABclonal; 1:1000 for WB, 1:100 for IF), rabbit anti-β-Tubulin antibody (10068-1-AP, Proteintech; 1:1000 for WB), mouse anti-α/β-Tubulin antibody (ab44928, Abcam; 1:100 for IF), mouse anti-GAPDH antibody (AC002, ABclonal; 1:10,000 for WB), mouse anti-Ac-Tubulin antibody (T7451, Sigma-Aldrich; 1:200 for IF), mouse anti-NME5 antibody (12923-1-AP, Proteintech; 1:1000 for WB), rabbit anti-DYNLL2 antibody (16811-1-AP, Proteintech; 1:1000 for WB), rabbit anti-TEKT2 antibody (13518-1-AP, Proteintech; 1:1000 for WB), rabbit anti-SPACA9 antibody (26034-1-AP, Proteintech; 1:1000 for WB), rabbit anti-PPIL6 antibody (17452-1-AP, Proteintech; 1:1000 for WB), rabbit anti-NME5 antibody (12923-1-AP, Proteintech; 1:1000 for WB),
Techniques: Transfection, Staining, Immunofluorescence, Co-Immunoprecipitation Assay, Magnetic Beads, Western Blot
Journal: American Journal of Translational Research
Article Title: DNMT3b-mediated SPAG6 promoter hypermethylation affects lung squamous cell carcinoma development through the JAK/STAT pathway
doi:
Figure Lengend Snippet: RT-qPCR primers used in this study
Article Snippet:
Techniques:
Journal: American Journal of Translational Research
Article Title: DNMT3b-mediated SPAG6 promoter hypermethylation affects lung squamous cell carcinoma development through the JAK/STAT pathway
doi:
Figure Lengend Snippet: Reduced expression of SPAG6 in LUSC is associated with its DNA hypermethylation. A: Hypermethylation of the genome of LUSC patients. B: Key hypermethylated CpG islands in LUSC. C: Methylation of cg14055896 and cg10648197 in LUSC. D: Querying the expression of CACNG8 in LUSC in GEPIA (T refers to tumor and N refers to normal). E: Querying the expression of SPAG6 in LUSC in GEPIA (T refers to tumor and N refers to normal). F: Methylation levels of CpG islands of SPAG6 in LUSC. G: Correlation between the expression of SPAG6 and the methylation level of CpG islands in LUSC. H: The prognostic significance of SPAG6 expression to the patients with LUSC. SPAG6, Sperm Associated Antigen 6; LUSC, Lung Squamous Cell Carcinoma; CpG, Cytosine and Guanine.
Article Snippet:
Techniques: Expressing, Methylation
Journal: American Journal of Translational Research
Article Title: DNMT3b-mediated SPAG6 promoter hypermethylation affects lung squamous cell carcinoma development through the JAK/STAT pathway
doi:
Figure Lengend Snippet: SPAG6 promoter hypermethylation is associated with poor prognosis of LUSC patients. (A) DNA methylation levels in the SPAG6 promoter region in LUSC tissues and adjacent normal tissues (n = 45) by MeDIP assays. (B) Detection of SPAG6 expression in LUSC tissues and adjacent normal tissues by RT-qPCR (n = 45). (C) The correlation between SPAG6 expression in LUSC tissues and its promoter DNA methylation level (n = 45) by Pearson’s correlation analysis. (D) DNA methylation levels in the promoter region of SPAG6 in the LUSC cell lines NCI-H1703 and SK-MES-1 and human normal lung epithelial cells BEAS-2B by MeDIP. (E) Detection of SPAG6 expression in LUSC cell lines NCI-H1703 and SK-MES-1 and human normal lung epithelial cells BEAS-2B by RT-qPCR. (F) The effect of decitabine treatment on the DNA methylation level of SPAG6 in LUSC cells by MeDIP assay. (G) Effect of Decitabine treatment on the expression of SPAG6 in LUSC cells by RT-qPCR. Data represent mean ± SD from three independent experiments were analyzed using paired t-test (A, B) or one-way (D, E)/two-way ANOVA (F, G) (*P < 0.05). SPAG6, Sperm Associated Antigen 6; LUSC, Lung Squamous Cell Carcinoma.
Article Snippet:
Techniques: DNA Methylation Assay, Methylated DNA Immunoprecipitation, Expressing, Quantitative RT-PCR
Journal: American Journal of Translational Research
Article Title: DNMT3b-mediated SPAG6 promoter hypermethylation affects lung squamous cell carcinoma development through the JAK/STAT pathway
doi:
Figure Lengend Snippet: Correlations between SPAG6 and clinical characteristics in 45 LUSC patients
Article Snippet:
Techniques: Expressing
Journal: American Journal of Translational Research
Article Title: DNMT3b-mediated SPAG6 promoter hypermethylation affects lung squamous cell carcinoma development through the JAK/STAT pathway
doi:
Figure Lengend Snippet: SPAG6 promoter methylation is regulated by DNMT3b. (A) Correlation between CpG island methylation status of SPAG6 and physiological data of patients. (B) Correlation between the expression of DNMTs and SPAG6 expression in LUSC was queried in GEPIA. (C) Binding relationship between DNMT3b and SPAG6 promoter region. (D) Detection of DNMT3b expression in LUSC tissues and adjacent normal tissues (n = 45) by RT-qPCR. (E) Correlation between DNMT3b expression and SPAG6 promoter DNA methylation levels in LUSC tissues (n = 45) by Person’s correlation analysis. (F) Correlation between DNMT3b expression and SPAG6 expression in LUSC tissues (n = 45) by Pearson’s correlation analysis. (G) Expression of DNMT3b in LUSC cell lines NCI-H1703 and SK-MES-1 and human normal lung epithelial cells BEAS-2B by RT-qPCR. (H) Effect of DNMT3b inhibition on the DNMT3b and SPAG6 expression in LUSC cell lines by RT-qPCR. (I) Effect of DNMT3b inhibition on the DNA methylation level of SPAG6 by MeDIP assay. Data represent mean ± SD from three independent experiments and were analyzed using paired t-test (D) or one-way (G)/two-way (H, I) ANOVA (*P < 0.05). SPAG6, Sperm Associated Antigen 6; LUSC, Lung Squamous Cell Carcinoma; DNMT, DNA Methyltransferase.
Article Snippet:
Techniques: Methylation, Expressing, Binding Assay, Quantitative RT-PCR, DNA Methylation Assay, Inhibition, Methylated DNA Immunoprecipitation
Journal: American Journal of Translational Research
Article Title: DNMT3b-mediated SPAG6 promoter hypermethylation affects lung squamous cell carcinoma development through the JAK/STAT pathway
doi:
Figure Lengend Snippet: Restoration of DNMT3b inhibits migration and invasion of LUSC cells. A: The expression of SPAG6 following the transfection of overexpression vectors containing SPAG6 in LUSC cells by RT-qPCR. B: Effect of overexpression of SPAG6 on cell proliferation by CCK8 assays. C: Effect of overexpression of SPAG6 on cellular DNA synthesis by EdU staining. D: Effect of overexpression of SPAG6 on the ability of cells to migrate by Transwell assay. E: Effect of overexpression of SPAG6 on the ability of cells to invade by Transwell assay. Data represent mean ± SD from three independent experiments and were analyzed using two-way ANOVA (A-E) (*P < 0.05). SPAG6, Sperm Associated Antigen 6; LUSC, Lung Squamous Cell Carcinoma.
Article Snippet:
Techniques: Migration, Expressing, Transfection, Over Expression, Quantitative RT-PCR, DNA Synthesis, Staining, Transwell Assay
Journal: American Journal of Translational Research
Article Title: DNMT3b-mediated SPAG6 promoter hypermethylation affects lung squamous cell carcinoma development through the JAK/STAT pathway
doi:
Figure Lengend Snippet: SPAG6 mediates the JAK/STAT pathway in LUSC. (A) Factors with significant correlation with SPAG6 expression in LUSC (only the top 25 factors were shown in the heatmap). (B) The pathway affected by SPAG6 analyzed using KEGG pathway enrichment analysis. (C) The mapping of STAT1 and STAT3 luciferase reporter gene plasmids. (D) Effect of SPAG6 on the luciferase activity of STAT1 and STAT3 luciferase reporter gene plasmids by dual-luciferase assays. Data represent mean ± SD from three independent experiments and were analyzed using two-way ANOVA (D) (*P < 0.05). SPAG6, Sperm Associated Antigen 6; LUSC, Lung Squamous Cell Carcinoma.
Article Snippet:
Techniques: Expressing, Luciferase, Activity Assay
Journal: American Journal of Translational Research
Article Title: DNMT3b-mediated SPAG6 promoter hypermethylation affects lung squamous cell carcinoma development through the JAK/STAT pathway
doi:
Figure Lengend Snippet: SPAG6 correlates with immune response in LUSC. A: Expression of SPAG6 in cancers and the correlation with immune cell infiltration. B: Correlation of SPAG6 expression with infiltration of naive B cells in LUSC. C: Correlation of SPAG6 expression with infiltration of monocytes in LUSC. D: Correlation of SPAG6 expression with infiltration of dendritic cells in LUSC. E: Correlation of SPAG6 expression with infiltration of mast cells in LUSC. F: Correlation between SPAG6 expression and expression of immunoregulatory genes in cancers. SPAG6, Sperm Associated Antigen 6; LUSC, Lung Squamous Cell Carcinoma.
Article Snippet:
Techniques: Expressing
Journal: American Journal of Translational Research
Article Title: DNMT3b-mediated SPAG6 promoter hypermethylation affects lung squamous cell carcinoma development through the JAK/STAT pathway
doi:
Figure Lengend Snippet: SPAG6 correlates with cancer cell stemness in LUSC. A: Correlation of SPAG6 expression with cancer stemness. B: Effect of overexpression of SPAG6 on the cancer cell stemness marker Nanog by RT-qPCR. C: Effect of overexpression of SPAG6 on the cancer cell stemness marker ALDH1 by RT-qPCR. D: Effect of overexpression of SPAG6 on the cancer cell stemness marker Sox2 by RT-qPCR. Data represent mean ± SD from three independent experiments and were analyzed using two-way ANOVA (B-D) (*P < 0.05). SPAG6, Sperm Associated Antigen 6; LUSC, Lung Squamous Cell Carcinoma; ALDH1, Aldehyde Dehydrogenase 1.
Article Snippet:
Techniques: Expressing, Over Expression, Marker, Quantitative RT-PCR